Interview: Nobel chemistry laureate Jennifer Doudna on the promise and peril of the genetic editing revolution
By John Mecklin,
Bulletin of the Atomic Scientists
| 12. 07. 2020
Just weeks after I interviewed her this September, UC Berkeley professor Jennifer Doudna and her colleague Emmanuelle Charpentier were jointly awarded the Nobel Prize in Chemistry for their discovery of the CRISPR/Cas9 genetic editing tool. An acronym for Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR sequences were found in bacteria, where they protect against viruses by chopping them into pieces. Doudna and Charpentier devised a way to reprogram these genetic scissors, so they could be directed to cut any DNA molecule at a predetermined site.
The CRISPR/Cas9 editing tool has greatly reduced the amount of time needed to edit genes and is now in use by researchers around the world. “There is enormous power in this genetic tool, which affects us all. It has not only revolutionized basic science, but also resulted in innovative crops and will lead to ground-breaking new medical treatments,” Claes Gustafsson, chair of the Nobel Committee for Chemistry, said in a press release accompanying the Nobel Prize announcement.
The positive potential of CRISPR editing tools is indeed breathtaking. “This tool has contributed to many important discoveries...
Related Articles
By Anumita Kaur [cites CGS’ Katie Hasson], The Washington Post | 03.25.2025
Genetic information company 23andMe has said that it is headed to bankruptcy court, raising questions for what happens to the DNA shared by millions of people with the company via saliva test kits.
Sunday’s announcement clears the way for a new...
By Peter Wehling, Tino Plümecke, and Isabelle Bartram
| 03.26.2025
This article was originally published as “Soziogenomik und polygene Scores” in issue 272 (February 2025) of the German-language journal Gen-ethischer Informationsdienst (GID); translated by the authors.
In mid-November 2024, the British organization Hope not Hate published its investigative research ‘Inside the Eugenics Revival’. In addition to documentating an active international “race research” network, the investigation also brought to light the existence of a US start-up that offers eugenic embryo selection. Heliospect Genomics aims to enable wealthy couples to...
By Frank Landymore, Futurism | 03.18.2025
You can only throw so much money at a problem.
This, more or less, is the line being taken by AI researchers in a recent survey. Asked whether "scaling up" current AI approaches could lead to achieving artificial general...
By Craig S. Smith, Forbes | 03.08.2025
One recent evening in Shenzhen, a group of software engineers gathered in a dimly lit co-working space, furiously typing as they monitored the performance of a new AI system. The air was electric, thick with the hum of servers and...